全文获取类型
收费全文 | 13549篇 |
免费 | 517篇 |
国内免费 | 235篇 |
专业分类
耳鼻咽喉 | 200篇 |
儿科学 | 345篇 |
妇产科学 | 1071篇 |
基础医学 | 1681篇 |
口腔科学 | 227篇 |
临床医学 | 1007篇 |
内科学 | 2879篇 |
皮肤病学 | 502篇 |
神经病学 | 899篇 |
特种医学 | 259篇 |
外科学 | 2489篇 |
综合类 | 128篇 |
一般理论 | 2篇 |
预防医学 | 915篇 |
眼科学 | 226篇 |
药学 | 795篇 |
中国医学 | 69篇 |
肿瘤学 | 607篇 |
出版年
2021年 | 153篇 |
2019年 | 133篇 |
2018年 | 188篇 |
2017年 | 163篇 |
2016年 | 210篇 |
2015年 | 239篇 |
2014年 | 255篇 |
2013年 | 413篇 |
2012年 | 463篇 |
2011年 | 529篇 |
2010年 | 354篇 |
2009年 | 307篇 |
2008年 | 504篇 |
2007年 | 555篇 |
2006年 | 616篇 |
2005年 | 632篇 |
2004年 | 596篇 |
2003年 | 576篇 |
2002年 | 611篇 |
2001年 | 324篇 |
2000年 | 272篇 |
1999年 | 221篇 |
1998年 | 138篇 |
1997年 | 135篇 |
1996年 | 148篇 |
1995年 | 181篇 |
1994年 | 154篇 |
1993年 | 146篇 |
1992年 | 194篇 |
1991年 | 178篇 |
1990年 | 164篇 |
1989年 | 215篇 |
1988年 | 179篇 |
1987年 | 213篇 |
1986年 | 146篇 |
1985年 | 205篇 |
1984年 | 145篇 |
1983年 | 145篇 |
1982年 | 184篇 |
1981年 | 162篇 |
1980年 | 140篇 |
1979年 | 146篇 |
1978年 | 134篇 |
1977年 | 143篇 |
1976年 | 132篇 |
1975年 | 148篇 |
1974年 | 120篇 |
1973年 | 111篇 |
1968年 | 129篇 |
1967年 | 101篇 |
排序方式: 共有10000条查询结果,搜索用时 296 毫秒
71.
J. Ch. Letard 《Acta endoscopica》2005,35(3):401-405
72.
Cholesterol-lowering drugs and advanced prostate cancer incidence in a large U.S. cohort. 总被引:2,自引:0,他引:2
Eric J Jacobs Carmen Rodriguez Elizabeth B Bain Yiting Wang Michael J Thun Eugenia E Calle 《Cancer epidemiology, biomarkers & prevention》2007,16(11):2213-2217
BACKGROUND: 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors, commonly known as statins, account for the great majority of cholesterol-lowering drug use in the United States. Long-duration statin use was associated with substantially reduced risk of advanced prostate cancer in a recent large prospective study. METHODS: We examined the association between use of cholesterol-lowering drugs and prostate cancer incidence by disease stage and grade among 55,454 men in the Cancer Prevention Study II Nutrition Cohort. Proportional hazards modeling was used to calculate RRs. RESULTS: During follow-up from 1997 to 2003, we identified 3,413 cases of incident prostate cancer, including 317 cases of advanced prostate cancer. After adjustment for age, history of prostate-specific antigen testing, and other potential prostate cancer risk factors, current use of cholesterol-lowering drugs for 5 or more years was not associated with overall prostate cancer incidence (multivariate adjusted rate ratio, 1.06; 95% confidence interval, 0.93-1.20), but was associated with a marginally statistically significant reduction in risk of advanced prostate cancer (rate ratio, 0.60; 95% confidence interval, 0.36-1.00). CONCLUSION: These results provide some support for the hypothesis that long-term statin use is associated with reduced risk of advanced prostate cancer. 相似文献
73.
74.
Shlomo Kyzer M.D. Benjamin Mitmaker M.D. Ph.D. F.R.C.S. Philip H. Gordon M.D. F.R.C.S. F.A.C.S. Hyman Schipper M.D. Ph.D. F.R.C.P. Eugenia Wang Ph.D. 《Diseases of the colon and rectum》1992,35(9):879-883
The field change is one hypothesis concerning the development of colorectal carcinoma. Removal of a carcinoma without its entire surrounding altered mucosa may result in the development of a recurrence. S44, a monoclonal antibody directed against statin, a nuclear protein expressed in nonproliferating cells in either a quiescent or senescent state, was used to determine the rate of cell growth in colorectal mucosa at different distances from carcinomas. The specimens of 18 patients undergoing resection of a colorectal carcinoma were immediately opened after operation, and strips of mucosa were taken at distances of 1 cm, 5 cm, and 10 cm from the carcinoma. For each location, 10 longitudinally oriented crypts were evaluated for statin-positive cells identified by the presence of a dark brown peroxidase-conjugated antibody reaction product. The average percentage of statin-positive cells per crypt was significantly lower at a 1-cm distance from the carcinoma compared with the mucosa located 5 and 10 cm from the carcinoma (20.89±4.33 at 1 cm, 32.41±5.27 at 5 cm, and 34.23±6.45 at 10 cm). None of the calculated parameters showed any significant difference between the 5-cm and 10-cm locations. The fact that the proliferation rate of the mucosal cells returns to the normal level at 5 cm from the margin of the carcinoma suggests that cells located within this distance still retain proliferative potential even though they are morphologically indistinguishable from their normal counterparts. We conclude that failure to remove this transitional, potentially proliferative mucosa may result in subsequent development of anastomotic or perianastomotic recurrences.This study was conducted with support from the Sir Mortimer B. Davis-Jewish General Hospital Foundation and the American Physician Fellowship and with grants to Eugenia Wang from the Medical Research Council of Canada and from the National Institute on Aging of the National Institutes of Health of the U.S.A. 相似文献
75.
Dr. J. Menck Ch. Bertram J. Grüber W. Lierse 《European journal of trauma and emergency surgery》1992,18(6):321-324
The design of the tibial medullary nail can be improved in order to preserve intraosseus vessels by osteosynthesis of the tibia. The nutrient artery of the human tibia enters the compacta in an average height of 33% dorsally and is leaving it in a height of 50% of the tibial length. In the medullary cavity the vessel splits up. The main branch continues the distal course on the dorsal/dorsolateral side of the medullary cavity (endosteal). In the distal diaphysis this endosteal vessel is of great importance, since the periosteal blood supply in this region with high incidence of pseudarthrosis is guaranteed only by branches of the anterior tibial artery. Using a new unreamed tibial nail, which is flattened dorsally, it is possible to preserve the endostal main artery of the tibia. 相似文献
76.
77.
78.
Prevalence of the G20210A prothrombin gene mutation in Northwestern Greece and association with venous thromboembolism. 总被引:1,自引:0,他引:1
Ch G Zalavras S Giotopoulou E Dokou M Mitsis H V Ioannou C Tsaousi A Tzolou N Kolaitis G Vartholomatos 《International angiology》2003,22(1):55-57
AIM: The G20210A mutation of the prothrombin gene is a genetic risk factor for venous thromboembolism (VTE). Variability exists in the mutation prevalence in both normal individuals and VTE patients. The aim of this study was to determine the mutation prevalence in Northwestern Greece and evaluate its association with VTE. METHODS: Presence of the G20210A mutation was investigated using DNA analysis in 176 consecutive patients with a history of venous thrombosis or pulmonary embolism and in 300 healthy controls, all Caucasian residents of Northwestern Greece. RESULTS: The mutation was present 12 patients (6.8%) and 8 controls (2.7%). The odds ratio for presence of the mutation versus the normal genotype in VTE was 2.7 (95% CI: 1.1 to 6.7), which was statistically significant. The prevalence of the G20210A prothrombin gene mutation in Northwestern Greece is 2.7% (95% CI: 0.8% to 4.4%) with an allele frequency of 1.3% (95% CI: 0.4% to 2.3%). CONCLUSION: The G20210A mutation of the prothrombin gene is associated with VTE in the Caucasian residents of this geographic region. 相似文献
79.
Trauma und Berufskrankheit - Die Berufsgenossenschaft der chemischen Industrie hat eine Fall-Kontroll-Studie durchgeführt, um Effekte einer Interventionsstrategie des Sachbearbeiters zusammen... 相似文献
80.
Perioperative Hearing Impairment 总被引:4,自引:0,他引:4